| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | May 05, 2026 | Sale | $16.60 | 14,055 | 233,319 | 38,174 | May 05, 2026, 07:53 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2026 | Option/RSU Exercise | - | 8,608 | - | 54,035 | Apr 30, 2026, 05:38 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2026 | Sale | $16.65 | 2,388 | 39,749 | 51,647 | Apr 30, 2026, 05:38 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2026 | Option/RSU Exercise | - | 11,496 | - | 49,088 | Jan 30, 2026, 08:39 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2026 | Sale | $16.60 | 3,661 | 60,767 | 45,500 | Jan 30, 2026, 08:39 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Nov 03, 2025 | Sale | $12.56 | 6,284 | 78,931 | 37,592 | Nov 03, 2025, 07:14 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 30, 2025 | Option/RSU Exercise | - | 11,494 | - | 47,006 | Oct 30, 2025, 06:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 30, 2025 | Sale | $12.80 | 3,130 | 40,054 | 43,876 | Oct 30, 2025, 06:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Aug 01, 2025 | Sale | $11.03 | 5,402 | 59,598 | 35,512 | Aug 01, 2025, 05:09 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jul 30, 2025 | Option/RSU Exercise | - | 11,494 | - | 45,218 | Jul 30, 2025, 06:49 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jul 30, 2025 | Sale | $12.01 | 4,304 | 51,695 | 40,914 | Jul 30, 2025, 06:49 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | May 02, 2025 | Sale | $11.33 | 6,198 | 70,243 | 33,724 | May 02, 2025, 06:18 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2025 | Sale | $11.50 | 2,438 | 28,041 | 39,922 | Apr 30, 2025, 07:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2025 | Option/RSU Exercise | - | 8,636 | - | 42,360 | Apr 30, 2025, 07:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Mar 03, 2025 | Sale | $14.49 | 5,825 | 84,388 | 34,424 | Mar 03, 2025, 05:29 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2025 | Option/RSU Exercise | - | 8,636 | - | 42,360 | Jan 30, 2025, 07:43 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2025 | Sale | $19.85 | 2,811 | 55,809 | 39,803 | Jan 30, 2025, 07:43 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Nov 01, 2024 | Sale | $24.28 | 3,546 | 86,083 | 33,724 | Nov 01, 2024, 05:57 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 30, 2024 | Option/RSU Exercise | - | 8,636 | - | 39,638 | Oct 30, 2024, 08:30 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 30, 2024 | Sale | $24.31 | 2,368 | 57,554 | 37,270 | Oct 30, 2024, 08:30 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Aug 26, 2024 | Sale | $25.22 | 20,000 | 504,370 | 31,002 | Aug 26, 2024, 05:41 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Aug 01, 2024 | Sale | $21.45 | 3,477 | 74,576 | 51,102 | Aug 01, 2024, 07:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jul 30, 2024 | Option/RSU Exercise | - | 8,636 | - | 56,969 | Jul 30, 2024, 07:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jul 30, 2024 | Sale | $20.67 | 2,490 | 51,463 | 54,479 | Jul 30, 2024, 07:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jun 20, 2024 | Sale | $20.01 | 20,000 | 400,216 | 48,333 | Jun 20, 2024, 04:58 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | May 02, 2024 | Sale | $12.83 | 3,499 | 44,878 | 68,333 | May 02, 2024, 06:01 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2024 | Option/RSU Exercise | - | 4,886 | - | 73,219 | Apr 30, 2024, 06:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2024 | Sale | $12.04 | 1,387 | 16,703 | 71,832 | Apr 30, 2024, 06:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Feb 16, 2024 | Sale | $10.02 | 6,812 | 68,223 | 68,333 | Feb 16, 2024, 07:20 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2024 | Option/RSU Exercise | - | 4,886 | - | 76,816 | Jan 30, 2024, 06:53 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2024 | Sale | $7.99 | 1,671 | 13,352 | 75,145 | Jan 30, 2024, 06:53 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Dec 20, 2023 | Sale | $10.00 | 3,541 | 35,421 | 71,930 | Dec 21, 2023, 05:19 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Dec 19, 2023 | Sale | $10.00 | 10,906 | 109,093 | 75,471 | Dec 20, 2023, 04:55 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 31, 2023 | Sale | $5.20 | 1,080 | 5,613 | 86,377 | Nov 01, 2023, 04:41 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 30, 2023 | Option/RSU Exercise | - | 4,886 | - | 87,457 | Nov 01, 2023, 04:41 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jul 30, 2023 | Option/RSU Exercise | - | 4,886 | - | 83,816 | Aug 01, 2023, 04:28 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jul 31, 2023 | Sale | $9.65 | 1,245 | 12,020 | 82,571 | Aug 01, 2023, 04:28 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2023 | Option/RSU Exercise | - | 2,886 | - | 79,651 | May 02, 2023, 04:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | May 01, 2023 | Sale | $9.88 | 721 | 7,121 | 78,930 | May 02, 2023, 04:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2023 | Sale | $11.78 | 924 | 10,884 | 76,765 | Feb 01, 2023, 04:17 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jan 30, 2023 | Option/RSU Exercise | - | 2,886 | - | 77,689 | Feb 01, 2023, 04:17 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 30, 2022 | Option/RSU Exercise | - | 2,886 | - | 75,542 | Nov 01, 2022, 07:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Oct 31, 2022 | Sale | $12.88 | 739 | 9,519 | 74,803 | Nov 01, 2022, 07:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Jul 30, 2022 | Option/RSU Exercise | - | 2,886 | - | 73,408 | Aug 02, 2022, 05:46 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Aug 01, 2022 | Sale | $15.67 | 752 | 11,784 | 72,656 | Aug 02, 2022, 05:46 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | May 31, 2022 | Option/RSU Exercise | $0.84 | 68,333 | 57,400 | 70,522 | Jun 01, 2022, 04:57 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Apr 30, 2022 | Option/RSU Exercise | - | 2,886 | - | 2,886 | May 03, 2022, 07:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | May 02, 2022 | Sale | $11.75 | 697 | 8,190 | 2,189 | May 03, 2022, 07:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Feb 24, 2021 | Option/RSU Exercise | $1.76 | 35,419 | 62,297 | 35,419 | Feb 25, 2021, 04:18 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Feb 24, 2021 | Sale | $39.90 | 35,419 | 1,413,218 | 0 | Feb 25, 2021, 04:18 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Feb 22, 2021 | Option/RSU Exercise | $1.10 | 5,330 | 5,886 | 5,330 | Feb 23, 2021, 06:04 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Feb 22, 2021 | Sale | $39.93 | 5,330 | 212,839 | 0 | Feb 23, 2021, 06:04 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Feb 18, 2021 | Option/RSU Exercise | $0.84 | 13,583 | 11,410 | 13,583 | Feb 22, 2021, 04:09 PM | |
| NRIX | Nurix Therapeutics, Inc. | Houte Hans Van | Chief Financial Officer | Feb 18, 2021 | Sale | $35.46 | 13,583 | 481,621 | 10,443 | Feb 22, 2021, 04:09 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More